Legal & General Group PLC Pacific Biosciences Of California, Inc. Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 24,447 shares of PACB stock, worth $39,359. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,447

Previous 24,447 -0.0%

Holding current value

$39,359

Previous $30,000 3.33%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$0.91 - $1.45 $191,271 - $304,772	-210,188 Reduced 89.58%	24,447 $30,000
Q4 2024 Feb 13, 2025	SELL	$1.55 - $2.65 $25,940 - $44,350	-16,736 Reduced 6.66%	234,635 $429,000
Q2 2024 May 29, 2025	SELL	$1.36 - $3.65 $1,326 - $3,558	-975 Reduced 0.41%	234,635 $321,000
Q2 2024 Aug 14, 2024	BUY	$1.36 - $3.65 $21,434 - $57,527	15,761 Added 6.69%	251,371 $344,000
Q1 2024 May 29, 2025	BUY	$3.52 - $9.59 $3,432 - $9,350	975 Added 0.42%	235,610 $883,000

Q1 2024 May 14, 2024	SELL	$3.52 - $9.59 $2,330 - $6,348	-662 Reduced 0.28%	235,610 $883,000
Q4 2023 May 29, 2025	BUY	$5.97 - $10.36 $9,772 - $16,959	1,637 Added 0.7%	236,272 $2.32 Million
Q4 2023 Feb 15, 2024	BUY	$5.97 - $10.36 $11,396 - $19,777	1,909 Added 0.81%	236,272 $2.32 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $62,021 - $104,976	7,536 Added 3.32%	234,363 $1.96 Million
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $147,017 - $207,181	14,746 Added 6.95%	226,827 $3.02 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $179,102 - $271,135	22,557 Added 11.9%	212,081 $2.46 Million
Q4 2022 Feb 14, 2023	SELL	$5.67 - $11.2 $35,533 - $70,190	-6,267 Reduced 3.2%	189,524 $1.55 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $75,306 - $164,218	-19,162 Reduced 8.91%	195,791 $1.14 Million
Q2 2022 Aug 22, 2022	BUY	$4.02 - $10.43 $173,446 - $450,012	43,146 Added 25.11%	214,953 $950,000
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $35,026 - $86,839	4,155 Added 2.48%	171,807 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $1,502 - $2,346	78 Added 0.05%	167,652 $3.43 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $796,763 - $1.12 Million	32,050 Added 23.65%	167,574 $4.28 Million
Q2 2021 Aug 12, 2021	BUY	$22.3 - $36.02 $242,467 - $391,645	10,873 Added 8.72%	135,524 $4.74 Million
Q1 2021 May 17, 2021	BUY	$26.38 - $51.15 $1.73 Million - $3.35 Million	65,572 Added 110.99%	124,651 $4.15 Million
Q4 2020 Feb 12, 2021	BUY	$10.5 - $28.5 $20,968 - $56,914	1,997 Added 3.5%	59,079 $1.53 Million
Q3 2020 Nov 13, 2020	SELL	$3.61 - $9.87 $14,317 - $39,144	-3,966 Reduced 6.5%	57,082 $563,000
Q2 2020 Aug 14, 2020	SELL	$2.65 - $4.03 $12,587 - $19,142	-4,750 Reduced 7.22%	61,048 $211,000
Q1 2020 May 14, 2020	SELL	$2.36 - $5.26 $15,453 - $34,442	-6,548 Reduced 9.05%	65,798 $202,000
Q4 2019 Feb 13, 2020	BUY	$4.6 - $5.57 $172,923 - $209,387	37,592 Added 108.17%	72,346 $372,000
Q3 2019 Nov 13, 2019	BUY	$4.99 - $6.16 $29,251 - $36,109	5,862 Added 20.29%	34,754 $179,000
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.41 $11,034 - $13,812	1,864 Added 6.9%	28,892 $175,000
Q1 2019 May 15, 2019	BUY	$6.8 - $7.4 $4,841 - $5,268	712 Added 2.71%	27,028 $196,000
Q4 2018 Feb 15, 2019	BUY	$3.99 - $7.82 $33,220 - $65,109	8,326 Added 46.28%	26,316 $195,000
Q2 2018 Aug 10, 2018	SELL	$2.11 - $3.92 $8,146 - $15,135	-3,861 Reduced 17.67%	17,990 $64,000
Q1 2018 May 17, 2018	SELL	$2.05 - $3.23 $7,968 - $12,555	-3,887 Reduced 15.1%	21,851 $45,000
Q4 2017 Feb 13, 2018	BUY	$2.59 - $5.44 $66,661 - $140,014	25,738	25,738 $68,000

Others Institutions Holding PACB

# of Institutions

244

Shares Held

190M

Call Options Held

1.27M

Put Options Held

601K

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $362M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Pacific Biosciences Of California, Inc. Transaction History